Ault Milton C III - Jul 25, 2025 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Jul 25, 2025
Transactions value $
-$128,169
Form type
4
Date filed
7/29/2025, 04:55 PM
Previous filing
Jul 25, 2025
Next filing
Jul 31, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AULT MILTON C III Director, 10%+ Owner 11411 SOUTHERN HIGHLANDS PARKWAY, SUITE 190, LAS VEGAS /s/ Milton C. Ault, III 2025-07-29 0001212502

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Sale -$106K -36.5K -44.25% $2.90 46K Jul 25, 2025 By Ault Lending, LLC F1, F2
transaction ALZN Common Stock Sale -$22.3K -8.31K -18.06% $2.68 37.7K Jul 28, 2025 By Ault Lending, LLC F2
holding ALZN Common Stock 1.84K Jul 25, 2025 Direct
holding ALZN Common Stock 11.1K Jul 25, 2025 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 61 Jul 25, 2025 By Ault Life Sciences Fund, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.8976. The range of sales prices on the transaction date was $2.891 to $2.9129 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
F2 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.